MARKET

PRPH

PRPH

Prophase Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.93
+0.61
+7.33%
After Hours: 8.55 -0.38 -4.26% 19:39 10/23 EDT
OPEN
8.06
PREV CLOSE
8.32
HIGH
11.18
LOW
7.10
VOLUME
738.98K
TURNOVER
--
52 WEEK HIGH
11.18
52 WEEK LOW
1.200
MARKET CAP
103.63M
P/E (TTM)
-64.8511
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Cassava Sciences, Medigus leads healthcare gainers, Neovasc, ProPhase Labs among major losers
Gainers: Cassava Sciences (SAVA) +13%, Medigus (MDGS) +10%, STRATA Skin Sciences (SSKN) +9%, CASI Pharmaceuticals (CASI) +8%, BOQI International Medical (BIMI) +7%.Losers: Neovasc (NVCN) -14%, ProPhase Labs (PRPH) -14%, Milestone Pharmaceuticals (MIST) -13%, Aptose Biosciences (APTO) -9%, Aileron Therapeutics (ALRN) -7%.
Seekingalpha · 2d ago
ProPhase Labs to acquire Confucius Labs
ProPhase Labs (PRPH) inked a definitive agreement to acquire a New Jersey-based Clinical Laboratory Improvement Amendments accredited laboratory (Confucius Plaza Medical Laboratory) which is approved for a variety of important medical
Seekingalpha · 2d ago
ProPhase Labs Announces Definitive Agreement To Acquire CLIA Accredited Lab Certified For COVID-19 And Upper Respiratory Testing In All-Cash Transaction Valued At $2.5M
  DOYLESTOWN, Pennsylvania, Oct. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH), a diversified medical science and technology company, announced today a definitive agreement to acquire a Clinical
Benzinga · 2d ago
Selecta Biosciences, Haemonetics leads healthcare gainers; Anchiano Therapeutics, Iterum Therapeutics among major losers
Gainers: Selecta Biosciences (SELB) +18%, Haemonetics (HAE) +12%, Healthcare Services Group (HCSG) +11%, Phreesia (PHR) +10%, ProPhase Labs (PRPH) +9%.Losers: Anchiano Therapeutics (ANCN) -21%, Iterum Therapeutics (ITRM) -13%, Aileron Therapeutics (ALRN) -12%, Baudax Bio (BXRX) -11%, BOQI International Medical (BIMI) -10%.
Seekingalpha · 4d ago
ReWalk Robotics, Aldeyra Therapeutics leads healthcare gainers; Biomerica, Adaptimmune Therapeutics among major losers
Gainers: ReWalk Robotics (RWLK) +18%, Aldeyra Therapeutics (ALDX) +19%, ClearPoint Neuro (CLPT) +15%, ProPhase Labs (PRPH) +12%, Orchard Therapeutics (ORTX) +11%.Losers: Biomerica (BMRA) -20%, Adaptimmune Therapeutics (ADAP) -14%, Can-Fite BioPharma (CANF) -14%, FSD Pharma (HUGE) -13%, Alterity Therapeutics (ATHE) -9%.
Seekingalpha · 10/16 15:03
The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)
Benzinga · 10/07 11:30
AYX, SOL, LAC and CRBP among midday movers
Gainers: Pioneer Power Solutions (PPSI) +323%.Ocean Power Technologies (OPTT) +82%.Electro-Sensors (ELSE) +30%.Asia Pacific Wire & Cable (APWC) +28%.Alteryx (AYX) +27%.Piedmont Lithium (PLL) +26%.ReneSola (SOL) +25%.TOMI Environmental Solutions (TOMZ) +25%TransAct Technologies (TACT) +24%.Polar Power
Seekingalpha · 10/06 16:41
The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)
Benzinga · 10/06 12:24
More
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRPH. Analyze the recent business situations of Prophase Lab through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Institutional Holdings
Institutions: 21
Institutional Holdings: 508.94K
% Owned: 4.39%
Shares Outstanding: 11.60M
TypeInstitutionsShares
Increased
3
6.00K
New
5
-12.62K
Decreased
3
39.70K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
+0.35%
Food & Tobacco
+0.20%
Key Executives
Chairman/Chief Executive Officer/Director
Ted Karkus
Chief Financial Officer
Monica Brady
Independent Director
Jason Barr
Independent Director
Louis Gleckel
Independent Director
Warren Hirsch
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
11/20/2019
Dividend USD 0.25
12/02/2019
12/26/2018
Dividend USD 0
01/09/2019
12/26/2018
Special Dividend USD 0.25
01/09/2019
05/07/2018
Dividend USD 0
06/06/2018
05/07/2018
Special Dividend USD 1
06/06/2018
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About PRPH
ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of ProPhase Labs Inc stock information, including NASDAQ:PRPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRPH stock methods without spending real money on the virtual paper trading platform.